[Antiadrenergic rescue therapy with amiodarone in children with severe left ventricular dysfunction secondary to

Justo J Santiago1, Carmen A Mazzei de Dávila, Diego F Davila

  • 1Instituto de Investigaciones Cardiovasculares, Universidad de los Andes, Mérida, Venezuela. justos@ula.ve

Insights

This study evaluated a rescue protocol for children with scorpion envenomation and left ventricular dysfunction. The protocol, including amiodarone, effectively improved cardiac function and reduced sympathetic activation.

Area of Science:

  • Pediatric Cardiology
  • Toxicology
  • Critical Care Medicine

Context:

  • Scorpion envenomation in children can cause significant sympathetic nervous system activation.
  • This activation frequently leads to impaired left ventricular systolic function.
  • Severe cases require immediate and effective intervention to prevent adverse outcomes.

Purpose:

  • To assess the efficacy of a specific rescue protocol for managing severe left ventricular dysfunction in pediatric scorpion envenomation.
  • To evaluate the protocol's impact on cardiac function markers and sympathetic activity.

Summary:

  • A rescue protocol involving endotracheal intubation, mechanical ventilation, and specific intravenous medications (Dobutamine, Amiodarone, Furosemide) was administered to four children with severe left ventricular dysfunction post-scorpion envenomation.
  • Cardiac function (ejection fraction) and serum levels of norepinephrine and troponin I were monitored over 48 hours.
  • The protocol demonstrated significant improvements in ejection fraction and reductions in norepinephrine and troponin I levels within 48 hours.

Impact:

  • The findings suggest that this rescue protocol can effectively manage acute left ventricular dysfunction in pediatric scorpion envenomation.
  • Amiodarone's role as a neuromodulator in decreasing norepinephrine levels is highlighted.
  • This research provides a potential therapeutic strategy for a life-threatening condition in children.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.